Home » Stocks » electroCore » News

electroCore, Inc. (ECOR)

Stock Price: $2.24 USD 0.01 (0.45%)
Updated Aug 7, 2020 4:00 PM EDT - Market closed
After-hours: $2.25 +0.01 (0.45%) Aug 7, 7:58 PM
GlobeNewsWire - 2 days ago

Conference Call to be Held at 4:30pm Eastern Time Conference Call to be Held at 4:30pm Eastern Time

24/7 Wall Street - 1 week ago

Whether it’s all speculation or day trading, it seems there is no end to seeing major gains in small and micro-cap stocks that have positive announcements around anything to do with testing, v...

GlobeNewsWire - 1 week ago

Initial distribution to hospitals and patients expected to begin on July 31st Initial distribution to hospitals and patients expected to begin on July 31st

InvestorPlace - 1 week ago

Bioelectronic medicine's crucial role has come into focus with Covid-19, and a recent FDA approval practically assures ECOR stock's ascent. The post FDA Green Light Makes ElectroCore a Micro-...

GlobeNewsWire - 1 week ago

Paper supports use of nVNS as a front-line therapy for acute and preventative treatment of cluster headache and as an effective option for the treatment of migraine headache Paper supports use...

GlobeNewsWire - 3 weeks ago

BASKING RIDGE, N.J., July 16, 2020 (GLOBE NEWSWIRE) -- In a release issued under the same headline on July 14, 2020, the company’s cash was incorrectly stated as being as of the end of the f...

GlobeNewsWire - 3 weeks ago

BASKING RIDGE, N.J., July 14, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today provided an operating and business update as...

InvestorPlace - 3 weeks ago

ElectroCore (ECOR) news for Monday concerning emergency authorization from the FDA for one of its drugs to treat coronavirus. The post ElectroCore News: Why ECOR Stock Is Skyrocketing 142% Tod...

Market Watch - 3 weeks ago

Shares of electroCore Inc. ECOR, +142.94% more than doubled (up 155%) on very heavy volume in afternoon trading Monday, after the bioelectronic medicine company said it was issued an emergency...

GlobeNewsWire - 3 weeks ago

Intended use allows gammaCore Sapphire CV use at home or in a healthcare setting Intended use allows gammaCore Sapphire CV use at home or in a healthcare setting

GlobeNewsWire - 4 weeks ago

BASKING RIDGE, N.J., July 09, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced today that Dan Goldberger, Chief Executi...

Forbes - 1 month ago

As the virus spreads, if you’re looking to bet against the market or hedge, our deep learning algorithms paired with out Artificial Intelligence (“AI”) data has some Top Shorts named for you t...

Stocks mentioned: BCRX, ECOR, PDSB, TTPH, CRDF
Forbes - 1 month ago

If you’re looking to hedge some downside, or if you think the market has gone too far to the upside, our deep learning algorithms have used Artificial Intelligence (“AI”) technology to identif...

Stocks mentioned: ECOR, GRUB, OCGN, RCL, SAGE
Forbes - 1 month ago

Retail sales surging 18% in May fared well with the markets this morning, but with growing concerns over a Coronavirus resurgence, it's clear that volatility is just around the corner. We've u...

Stocks mentioned: ARCB, ECOR, FLNT, GRUB, NAVB
Forbes - 1 month ago

With the S&P 500, Nasdaq, and Dow going positive today, we link the markets are overextended. Our deep learning and AI has identified several Top Shorts today for you to hedge your portfolio w...

Stocks mentioned: BLNK, COCP, ECOR, TTPH
Forbes - 1 month ago

We have some buying this morning with markets recovering some of Thursday’s massive losses. However, it looks uneasy at best.

Stocks mentioned: COCP, ECOR, INSE, KMPH
Seeking Alpha - 2 months ago

electroCore: Promising Product Means New Management Team Can Complete Unlikely Turnaround

Seeking Alpha - 2 months ago

electroCore, Inc. (ECOR) CEO Dan Goldberger on Q1 2020 Results - Earnings Call Transcript

Zacks Investment Research - 2 months ago

electroCore, Inc. (ECOR) delivered earnings and revenue surprises of -4.00% and 0.55%, respectively, for the quarter ended March 2020.

GlobeNewsWire - 2 months ago

Generated first quarter revenue of $734,000

Seeking Alpha - 3 months ago

Daily Insider Ratings Round Up 4/16/20

Stocks mentioned: ECOR, EHI, OPK, PHD, RHP, SPWR, SRC, JPM, PIH
GlobeNewsWire - 3 months ago

BASKING RIDGE, N.J., April 17, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today provided a business update, and introduced ...

GlobeNewsWire - 4 months ago

ITP program reimbursing for gammaCore™ extended to Sept. 30, 2020 ITP program reimbursing for gammaCore™ extended to Sept. 30, 2020

Benzinga - 4 months ago

ElectroCore, Inc (NASDAQ: ECOR) shares are trading higher on Friday, after the company announced it has submitted an emergency use authorization application to the FDA to allow the study and u...

Zacks Investment Research - 4 months ago

Top Ranked Momentum Stocks to Buy for April 3rd

Stocks mentioned: AYTU, CTMX, DHT, ECOR
GlobeNewsWire - 4 months ago

BASKING RIDGE, N.J., April 02, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that the company has submitted an...

Zacks Investment Research - 4 months ago

Top Ranked Momentum Stocks to Buy for March 31st

Stocks mentioned: ECOR, EURN, GO, SFM
GlobeNewsWire - 4 months ago

Approval makes novel non-invasive vagus nerve stimulation therapy available for prevention as well as acute treatment of migraines in adults Approval makes novel non-invasive vagus nerve stimu...

GlobeNewsWire - 4 months ago

BASKING RIDGE, N.J., March 27, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that it has entered into a common...

GlobeNewsWire - 4 months ago

John Gandolfo, Tom Patton and Peter Cuneo to join the Board, adding significant medical technology operational, financial and turn-around experience John Gandolfo, Tom Patton and Peter Cuneo t...

Seeking Alpha - 4 months ago

electroCore, Inc. (ECOR) CEO Dan Goldberger on Q4 2019 Results - Earnings Call Transcript

GlobeNewsWire - 6 months ago

Agreement opens reimbursement pathway for thousands of patients with migraine and cluster headache Agreement opens reimbursement pathway for thousands of patients with migraine and cluster hea...

GlobeNewsWire - 7 months ago

BASKING RIDGE, N.J., Dec. 27, 2019 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that the company’s current Chairma...

GlobeNewsWire - 8 months ago

NICE has today published a medical technologies guidance document recommending the use of gammaCore within the NHS for the acute and preventive treatment of cluster headache in the U.K. NICE h...

GlobeNewsWire - 8 months ago

BASKING RIDGE, N.J., Nov. 26, 2019 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that Dan Goldberger, Chief Executi...

Seeking Alpha - 8 months ago

electroCore's (ECOR) CEO Dan Goldberger on Q3 2019 Results - Earnings Call Transcript

GlobeNewsWire - 10 months ago

BASKING RIDGE, N.J., Sept. 30, 2019 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced the appointment of Daniel S. Gold...

Zacks Investment Research - 10 months ago

Top Ranked Momentum Stocks to Buy for September 20th

Stocks mentioned: ECOR, EDAP, ESTC
Zacks Investment Research - 11 months ago

As of late, it has definitely been a great time to be an investor in electroCore, Inc. (ECOR).

Zacks Investment Research - 11 months ago

Top Ranked Momentum Stocks to Buy for August 19th

Stocks mentioned: BLDR, CPRX, ECOR, WW
Seeking Alpha - 11 months ago

electroCore, Inc. (ECOR) CEO Frank Amato on Q2 2019 Results - Earnings Call Transcript

Seeking Alpha - 1 year ago

electroCore, Inc. (ECOR) CEO Frank Amato on Q1 2019 Results - Earnings Call Transcript

Seeking Alpha - 1 year ago

electroCore, Inc. (ECOR) CEO Frank Amato on Q4 2018 Results - Earnings Call Transcript

Forbes - 1 year ago

Year to date, the market has gifted investors a 9.92% return, but it remains off 5.73% from the start of the fourth quarter. While many investors are enjoying a lift in their stocks, the Ben G...

Stocks mentioned: DFFN, ECOR, SPEX

Latest From StockTwits